ArticleBioinformatics advances2026
The impact of biologically relevant negative samples on machine learning-based B-cell epitope prediction for Influenza A.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Predicting linear B-cell epitopes remains a major challenge in immunoinformatics, particularly for rapidly evolving viruses such as Influenza A. Many existing predictors rely on heterogeneous training datasets, poorly defined negative samples, or low-interpretability models, which can limit performance on pathogen-specific tasks. Improving prediction therefore requires biologically meaningful datasets together with informative and interpretable sequence representations. Results: We developed a machine learning framework based on sequence-derived physicochemical descriptors for linear B-cell epitope prediction in Influenza A. A curated dataset of experimentally validated epitopes and non-epitopes was constructed using redundancy reduction and balanced sampling strategies. Five supervised classifiers were evaluated, and the effect of real versus artificial negative datasets was systematically assessed. Feature selection using Analysis of Variance and Mutual Information showed that predictive performance emerged from the combined contribution of multiple descriptors rather than single variables. The best model, Random Forest, achieved 82% accuracy, 83% F1-score, a Matthews correlation coefficient of 0.65, and an area under the receiver operating characteristic curve of 0.90. Benchmarking against widely used tools showed improved balanced performance on our curated Influenza A dataset. Availability and implementation: Source code, processed datasets, and reproducible analysis scripts are freely available at GitHub: https://github.com/cparejabarrueto/epitopes.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.